PharmiWeb.com - Global Pharma News & Resources
31-Jan-2019

Radiation Toxicity - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Radiation Toxicity - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Radiation Toxicity - Pipeline Insight, 2019 offers a comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Radiation Toxicity development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope

  • The report provides a snapshot of the pipeline development for the Radiation Toxicity
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Radiation Toxicity
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Radiation Toxicity
  • The report also covers the dormant and discontinued pipeline projects related to Radiation Toxicity

Topics Covered

1. Report Introduction

2. Radiation Toxicity Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Radiation Toxicity

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Featured

  • Aeolus Pharmaceuticals Inc.
  • Angion Biomedica Corp.
  • Atox Bio Ltd.
  • BCN Biosciences LLC
  • Bolder Biotechnology Inc.
  • Cellerant Therapeutics Inc.
  • Cellphire Inc.
  • Chrysalis BioTherapeutics Inc.
  • Cleveland BioLabs Inc.
  • Daiichi Sankyo Company Ltd.
  • FirstString Research Inc.
  • Foresee Pharmaceuticals LLC
  • Galera Therapeutics Inc.
  • GSK:Genzyme Corp.
  • GNI Group Ltd.
  • Humanetics Corp.
  • Insys Therapeutics Inc.

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bmxwg4/radiation?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190131005800/en/

Editor Details

Last Updated: 31-Jan-2019